Genetic mutagenesis of TRF2 or telomerase genes induces pulmonary fibrosis [58,78], whereas transgenically expressing TERT holds a therapeutic potential in alleviating pulmonary fibrosis [158]. The gene discussed is TERT; the disease is pulmonary fibrosis.